Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery

Xiao Li, Zhongguo Sui, Xin Li, Wen Xu, Qie Guo, Jialin Sun, Fanbo Jing Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of China Abstract: Perfluorooctylbromide nanoparticles (PFOB NPs) are a type of multifunctional nano...

Full description

Bibliographic Details
Main Authors: Li X, Sui Z, Xu W, Guo Q, Sun J, Jing F
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/perfluorooctylbromide-nanoparticles-for-ultrasound-imaging-and-drug-de-peer-reviewed-article-IJN
_version_ 1831633583539748864
author Li X
Sui Z
Li X
Xu W
Guo Q
Sun J
Jing F
author_facet Li X
Sui Z
Li X
Xu W
Guo Q
Sun J
Jing F
author_sort Li X
collection DOAJ
description Xiao Li, Zhongguo Sui, Xin Li, Wen Xu, Qie Guo, Jialin Sun, Fanbo Jing Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of China Abstract: Perfluorooctylbromide nanoparticles (PFOB NPs) are a type of multifunctional nanotechnology that has been studied for various medical applications. Commercial ultrasound contrast agents (UCAs) suffer from the following limitations: short half-lives in vivo, high background signal and restricted distribution in the vascular circulation due to their micrometer dimensions. PFOB NPs are new potential UCAs that persist for long periods in the circulatory system, possess a relatively stable echogenic response without increasing the background signal and exhibit lower acoustic attenuation than commercial UCAs. Furthermore, PFOB NPs may also serve as drug delivery vehicles in which drugs are dissolved in the outer lipid or polymer layer for subsequent delivery to target sites in site-targeted therapy. The use of PFOB NPs as carriers has the potential advantage of selectively delivering payloads to the target site while improving visualization of the site using ultrasound (US) imaging. Unfortunately, the application of PFOB NPs to the field of ultrasonography has been limited because of the low intensity of US reflection. Numerous researchers have realized the potential use of PFOB NPs as UCAs and thus have developed alternative approaches to apply PFOB NPs in ultrasonography. In this article, we review the latest approaches for using PFOB NPs to enhance US imaging in vivo. In addition, this article emphasizes the application of PFOB NPs as promising drug delivery carriers for cancer and atherosclerosis treatments, as PFOB NPs can transport different drug payloads for various applications with good efficacy. We also note the challenges and future study directions for the application of PFOB NPs as both a delivery system for therapeutic agents and a diagnostic agent for ultrasonography. Keywords: perfluorooctylbromide nanoparticles, ultrasound enhancement, drug delivery, therapy coupled with diagnosis
first_indexed 2024-12-19T05:39:43Z
format Article
id doaj.art-bded7465b1654616a47157140f0af35c
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-19T05:39:43Z
publishDate 2018-05-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-bded7465b1654616a47157140f0af35c2022-12-21T20:34:03ZengDove Medical PressInternational Journal of Nanomedicine1178-20132018-05-01Volume 133053306738533Perfluorooctylbromide nanoparticles for ultrasound imaging and drug deliveryLi XSui ZLi XXu WGuo QSun JJing FXiao Li, Zhongguo Sui, Xin Li, Wen Xu, Qie Guo, Jialin Sun, Fanbo Jing Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of China Abstract: Perfluorooctylbromide nanoparticles (PFOB NPs) are a type of multifunctional nanotechnology that has been studied for various medical applications. Commercial ultrasound contrast agents (UCAs) suffer from the following limitations: short half-lives in vivo, high background signal and restricted distribution in the vascular circulation due to their micrometer dimensions. PFOB NPs are new potential UCAs that persist for long periods in the circulatory system, possess a relatively stable echogenic response without increasing the background signal and exhibit lower acoustic attenuation than commercial UCAs. Furthermore, PFOB NPs may also serve as drug delivery vehicles in which drugs are dissolved in the outer lipid or polymer layer for subsequent delivery to target sites in site-targeted therapy. The use of PFOB NPs as carriers has the potential advantage of selectively delivering payloads to the target site while improving visualization of the site using ultrasound (US) imaging. Unfortunately, the application of PFOB NPs to the field of ultrasonography has been limited because of the low intensity of US reflection. Numerous researchers have realized the potential use of PFOB NPs as UCAs and thus have developed alternative approaches to apply PFOB NPs in ultrasonography. In this article, we review the latest approaches for using PFOB NPs to enhance US imaging in vivo. In addition, this article emphasizes the application of PFOB NPs as promising drug delivery carriers for cancer and atherosclerosis treatments, as PFOB NPs can transport different drug payloads for various applications with good efficacy. We also note the challenges and future study directions for the application of PFOB NPs as both a delivery system for therapeutic agents and a diagnostic agent for ultrasonography. Keywords: perfluorooctylbromide nanoparticles, ultrasound enhancement, drug delivery, therapy coupled with diagnosishttps://www.dovepress.com/perfluorooctylbromide-nanoparticles-for-ultrasound-imaging-and-drug-de-peer-reviewed-article-IJNPerfluorooctylbromide nanoparticlesultrasound enhancementdrug deliverytherapy coupled with diagnosis.
spellingShingle Li X
Sui Z
Li X
Xu W
Guo Q
Sun J
Jing F
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
International Journal of Nanomedicine
Perfluorooctylbromide nanoparticles
ultrasound enhancement
drug delivery
therapy coupled with diagnosis.
title Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
title_full Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
title_fullStr Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
title_full_unstemmed Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
title_short Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
title_sort perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
topic Perfluorooctylbromide nanoparticles
ultrasound enhancement
drug delivery
therapy coupled with diagnosis.
url https://www.dovepress.com/perfluorooctylbromide-nanoparticles-for-ultrasound-imaging-and-drug-de-peer-reviewed-article-IJN
work_keys_str_mv AT lix perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT suiz perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT lix perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT xuw perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT guoq perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT sunj perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery
AT jingf perfluorooctylbromidenanoparticlesforultrasoundimaginganddrugdelivery